Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.48136 | 79 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 4.9535 | 75 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.1406 | 83 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.99192 | 81 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.85033 | 81 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.29132 | 69 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.01652 | 76 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.53979 | 79 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 6.07161 | 83 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.23076 | 84 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.87104 | 82 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.25299 | 84 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.81656 | 81 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.03809 | 83 |